New York, New York–(Newsfile Corp. – December 7, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Synopsys, Inc. (NASDAQ: SNPS) between December 4, 2024 and September 9, 2025, both dates inclusive (the “Class Period”), of the important December 30, 2025 lead plaintiff deadline. SO WHAT: If […]
Open Source Summit Japan- The Linux Foundation, the nonprofit organization enabling mass innovation through open source, today announced the publication of its latest research report, “The State of Open Source Japan 2025: Accelerating Business Value through Strategic Open Source Engagement.” The Japanese edition, “æ-¥æoeã®ãeã¼ã-ã³ãe½ã¼ãeã®ç¾çS 2025:æ^ç-¥çs”ããeã¼ã-ã³ãe½ã¼ãeæ'”ç”ã”ãe^ãe'ã”ãeããeä¾iåEUR nã®åSéEUR Y”, is being released simultaneously with the English version.
Mitsubishi Electric's membership upgrade from silver establishes the manufacturer as an active contributor to open source and critical presence in software development Open Source Summit Japan -The Linux Foundation, the nonprofit organization enabling mass innovation through open source, today announces Mitsubishi Electric Corporation has upgraded to a Gold Member of the foundation. As a leading
ChemLex, a next-generation AI-for-science company, today announced the establishment of its global headquarters and self-driving laboratory in Singapore, alongside the close of a USD 45 million funding round led by Granite Asia. Founded in 2022, ChemLex develops AI technologies that radically accelerate chemical discovery for the pharmaceutical industry, significantly reducing time-to-market. In just three and
AI/ML health-tech startupRespiree has received approval from the Health Sciences Authority (HSA) for its 1Bio™AI-Acute toolbox as a Class B software-as-a-medical device (SaMD). The solution is designed to support healthcare professionals in identifying acute inpatient deterioration using AI-enabled machine learning models. Compared to the current standard of care, 1Bio™AI-Acute delivers significantly higher precision in acute
As interest in “plant butlers” and “plant tech” continues to grow among people who care forhouseplants, IoT-based smart garden specialist ALLUONE Co., Ltd. has announced the launch of its 2025 home smart garden, “Watering Garden,” offering a new lifestyle that brings nature closer to urban living. ALLUONE plans to unveil “Watering Garden” at the Ilsan
ChemLex, a next-generation AI-for-science company, today announced the establishment of its global headquarters and self-driving laboratory in Singapore, alongside the close of a USD 45 million funding round led by Granite Asia. Founded in 2022, ChemLex develops AI technologies that radically accelerate chemical discovery for the pharmaceutical industry, significantly reducing time-to-market. In just three and
AI/ML health-tech startupRespiree has received approval from the Health Sciences Authority (HSA) for its 1Bio™AI-Acute toolbox as a Class B software-as-a-medical device (SaMD). The solution is designed to support healthcare professionals in identifying acute inpatient deterioration using AI-enabled machine learning models. Compared to the current standard of care, 1Bio™AI-Acute delivers significantly higher precision in acute
(NASDAQ:HCM),(LSE – AIM:HCM),(HKSE:0013), HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Dec. 08, 2025 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED“) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that following the contract renewal with the China National Healthcare Security Administration (“NHSA”), the updated National Reimbursement Drug List (“NRDL”) effective on January 1, 2026 will continue to include ELUNATE(R),
HUTCHMED Announces Expanded Coverage on National Reimbursement Drug List and Inclusion in the First Commercial Insurance Drug List in China GlobeNewswire December 08, 2025 HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Dec. 08, 2025 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED“) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that following the contract renewal with the China National